Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy
- PMID: 4359162
- PMCID: PMC1083612
- DOI: 10.1136/jnnp.36.6.1076
Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy
Abstract
The narcoleptic syndrome is a life-long and sometimes familial disorder in which there is a disturbance of the rapid eye movement phase of sleep. Patients with periodic sleep in the daytime but no other symptoms seldom develop the narcoleptic syndrome and have a separate unrelated disorder. Twelve patients with the narcoleptic syndrome were treated separately with l(-) amphetamine and d(+) amphetamine. Both drugs abolished narcolepsy, d(+) amphetamine being slightly more potent than l(-) amphetamine. In equipotent doses, unwanted effects of nervousness and insomnia were equal in frequency. No tolerance to either preparation developed during a six month period. Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine.
Similar articles
-
Narcolepsy in the older adult: epidemiology, diagnosis and management.Drugs Aging. 2003;20(5):361-76. doi: 10.2165/00002512-200320050-00005. Drugs Aging. 2003. PMID: 12696996 Review.
-
On the treatment of rapid eye movement narcolepsy.Arch Neurol. 1974 Jan;30(1):90-3. doi: 10.1001/archneur.1974.00490310092014. Arch Neurol. 1974. PMID: 4357130 No abstract available.
-
Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.Neuroscience. 2000;99(4):651-9. doi: 10.1016/s0306-4522(00)00239-6. Neuroscience. 2000. PMID: 10974428
-
The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy.Schweiz Arch Neurol Neurochir Psychiatr. 1971;108(2):251-60. Schweiz Arch Neurol Neurochir Psychiatr. 1971. PMID: 4330752 No abstract available.
-
Emerging treatments for narcolepsy and its related disorders.Expert Opin Emerg Drugs. 2010 Mar;15(1):139-58. doi: 10.1517/14728210903559852. Expert Opin Emerg Drugs. 2010. PMID: 20166851 Review.
Cited by
-
Tackling N-Alkyl Imines with 3d Metal Catalysis: Highly Enantioselective Iron-Catalyzed Synthesis of α-Chiral Amines.Angew Chem Int Ed Engl. 2020 Sep 7;59(37):15974-15977. doi: 10.1002/anie.202006557. Epub 2020 Jun 25. Angew Chem Int Ed Engl. 2020. PMID: 32453491 Free PMC article.
-
Uncertainty Evaluation for the Quantification of Urinary Amphetamine and 4-Hydroxyamphetamine Using Liquid Chromatography-Tandem Mass Spectrometry: Comparison of the Guide to the Expression of Uncertainty in Measurement Approach and the Monte Carlo Method with R.Molecules. 2023 Sep 25;28(19):6803. doi: 10.3390/molecules28196803. Molecules. 2023. PMID: 37836646 Free PMC article.
-
Amphetamines, growth hormone and narcolepsy.Br J Clin Pharmacol. 1977 Jun;4(3):343-9. doi: 10.1111/j.1365-2125.1977.tb00722.x. Br J Clin Pharmacol. 1977. PMID: 901702 Free PMC article.
-
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.J Clin Sleep Med. 2021 Sep 1;17(9):1895-1945. doi: 10.5664/jcsm.9326. J Clin Sleep Med. 2021. PMID: 34743790 Free PMC article.
-
Kleine-Levin syndrome with periodic apnea during hypersomnic stages--E.E.G. study.J Neural Transm. 1978;43(2):121-32. doi: 10.1007/BF01579071. J Neural Transm. 1978. PMID: 32228
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources